cbdMD, Inc. logo

cbdMD, Inc. (YCBD)

Market Closed
5 Dec, 20:00
AMEX AMEX
$
0. 61
-0
-0.23%
$
5.51M Market Cap
- P/E Ratio
0.27% Div Yield
156,363 Volume
- Eps
$ 0.61
Previous Close
Day Range
0.6 0.64
Year Range
0.47 6.54
Want to track YCBD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 9 days

Summary

YCBD closed Friday lower at $0.61, a decrease of 0.23% from Thursday's close, completing a monthly decrease of -0.13% or $0. Over the past 12 months, YCBD stock lost -79.87%.
YCBD is not paying dividends to its shareholders.
The last earnings report, released on Aug 13, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.17%, based on the last three reports. The next scheduled earnings report is due on Dec 17, 2025.
cbdMD, Inc. has completed 2 stock splits, with the recent split occurring on May 07, 2025.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on AMEX (USD).

YCBD Chart

Similar

NCL
Northann Corp.
$ 0.38
-6.87%
Network-1 Technologies Inc.
$ 1.43
-0.9%
LGL
LGL Group, Inc.
$ 5.82
+1.75%
BGI
Birks Group Inc.
$ 1.08
-1.04%
MI
Nft Ltd.
$ 4
-1.23%
cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript

cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript

cbdMD, Inc. (NYSE:YCBD ) Q2 2025 Earnings Conference Call May 15, 2025 4:20 PM ET Company Participants Brad Whitford – Chief Accounting Officer Ronan Kennedy – Chief Executive Officer and Chief Financial Officer Conference Call Participants Tom McGovern – Maxim Group Adam Waldo – Lismore Partners Operator Good afternoon. Welcome to the cbdMD, Inc. Conference Call to discuss results for their Second Quarter Fiscal 2025 period ending March 25, 2025.

Seekingalpha | 6 months ago
cbdMD, Inc. (YCBD) Q1 2025 Earnings Call Transcript

cbdMD, Inc. (YCBD) Q1 2025 Earnings Call Transcript

cbdMD, Inc. (NYSE:YCBD ) Q1 2025 Earnings Conference Call February 13, 2025 4:20 PM ET Company Participants Brad Whitford - Chief Accounting Officer Ronan Kennedy - Interim Chief Executive Officer and Chief Financial Officer Conference Call Participants Adam Waldo - Lismore Partners, LLC Thomas McGovern - Maxim Group Operator Good afternoon. Welcome to the cbdMD, Inc.'s December 31, 2024, First Fiscal Quarter of 2025 Earnings Call and Update.

Seekingalpha | 9 months ago
cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript

cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript

cbdMD, Inc. (NYSE:YCBD ) Q3 2024 Earnings Conference Call August 14, 2024 4:20 PM ET Company Participants Brad Whitford - Chief Accounting Officer Ronan Kennedy - Chief Executive Officer & Chief Financial Officer Conference Call Participants Thomas McGovern - Maxim Group Operator Good afternoon. Welcome to cbdMD's, Inc. June 30, 2024 Third Fiscal 2024 Quarter and Earnings Call and Update.

Seekingalpha | 1 year ago

cbdMD, Inc. (YCBD) FAQ

What is the stock price today?

The current price is $0.61.

On which exchange is it traded?

cbdMD, Inc. is listed on AMEX.

What is its stock symbol?

The ticker symbol is YCBD.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.27%.

What is its market cap?

As of today, the market cap is 5.51M.

When is the next earnings date?

The next earnings report will release on Dec 17, 2025.

Has cbdMD, Inc. ever had a stock split?

cbdMD, Inc. had 2 splits and the recent split was on May 07, 2025.

cbdMD, Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
T. Ronan Kennedy CEO
AMEX Exchange
12482W101 CUSIP
US Country
42 Employees
- Last Dividend
7 May 2025 Last Split
29 Apr 2019 IPO Date

Overview

cbdMD, Inc., a distinguished entity in the cannabis industry, specializes in the production and distribution of a wide array of cannabidiol (CBD) products. The company prides itself on its ownership and operation of prominent consumer hemp-based CBD brands, including cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Initially known as Level Brands, Inc., the organization underwent a rebranding to cbdMD, Inc. in May 2019, positioning itself more directly within the CBD market sphere. Based in Charlotte, North Carolina, cbdMD, Inc. strategically distributes its wellness products both online via e-commerce platforms and offline through select distributors, marketing partners, and brick and mortar retailers across the United States.

Products and Services

cbdMD Brand Products: The flagship cbdMD brand encompasses a diverse portfolio, featuring CBD tinctures, gummies, topicals, capsules, and drink mixes designed to cater to various wellness needs. These include aids for sleep, focus, and calming, tailored to enhance users' overall well-being and lifestyle.

Paw CBD: Recognizing the importance of pet health, cbdMD, Inc. extends its CBD expertise to the veterinarian-formulated Paw CBD line. This brand offers tinctures, chews, and topicals, all engineered to provide the health benefits of CBD to pets in a safe and effective manner.

ATRx Brand: Stepping into the burgeoning nootropic space, the ATRx brand by cbdMD, Inc. introduces a nootropic mushroom line. This innovative offering combines the holistic wellness properties of mushrooms with CBD, aiming to cater to consumers seeking cognitive enhancement and mental wellness solutions.

hempMD Brand: The hempMD brand represents the company's expansion into hemp-derived solutions, further broadening its product offerings. This line is designed to meet the growing demand for hemp-based wellness products, emphasizing purity, quality, and consumer trust.

cbdMD Botanicals: Catering to the skincare market, cbdMD Botanicals integrates the therapeutic properties of CBD into a range of skincare products. This line is dedicated to delivering natural, hemp-derived skincare solutions aimed at improving skin health and appearance.

Contact Information

Address: 8845 Red Oak Boulevard
Phone: 704 445 3060